Increasingly, it is necessary to justify the expense of providing additional effectiveness by comparing the value for the cost of alternative interventions (e.g. using cost-effectiveness analysis). While the statistical methodology for assessing, interpreting, and defending evidence of effectiveness is well developed, the methodology for the evaluation of costs is less so. The objective of this study is to advance the methods of evaluating costs as part of cost-effectiveness analysis and apply the new methods to clinical studies of alcohol treatments.
The aims of this proposal focus on addressing problem areas that potentially undermine the policy relevance and interpretability of economic evidence derived from clinical trials. These problem areas are: (1) Resource costing; (2) Estimating incremental costs of treatment; (3) Accommodating attrition in cost data; (4) Estimating sample size and power for cost-effectiveness; and (5) Generalizing cost and outcome information. Our approach will be to develop advancements in these areas, demonstrate our new methods using an NIAAA funded clinical trial, validate using simulation, and then disseminate. By developing the methodology of cost analysis we aim to improve the policy relevance and interpretability of economic evidence in trial based data.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA012664-02
Application #
6621309
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Hough, John F
Project Start
2002-03-01
Project End
2004-08-31
Budget Start
2003-03-01
Budget End
2004-02-29
Support Year
2
Fiscal Year
2003
Total Cost
$504,661
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Polsky, Daniel; Doshi, Jalpa A; Bauer, Mark S et al. (2006) Clinical trial-based cost-effectiveness analyses of antipsychotic use. Am J Psychiatry 163:2047-56
Doshi, Jalpa A; Glick, Henry A; Polsky, Daniel (2006) Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value Health 9:334-40
Manning, Willard G; Basu, Anirban; Mullahy, John (2005) Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 24:465-88
Basu, Anirban; Rathouz, Paul J (2005) Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics 6:93-109
Basu, Anirban; Manning, Willard G; Mullahy, John (2004) Comparing alternative models: log vs Cox proportional hazard? Health Econ 13:749-65
Hilton, Michael E; Fleming, Michael; Glick, Henry et al. (2003) Services integration and cost-effectiveness. Alcohol Clin Exp Res 27:271-80